New Algorithm Better Identifies Seizure Origin for More Precise Surgical Interventions
By HospiMedica International staff writers Posted on 11 Dec 2024 |

Epilepsy, affecting over 50 million people globally, is one of the most common neurological disorders. While many forms of epilepsy can be managed with medication, those with drug-resistant epilepsy often require surgical intervention to control their seizures. In such cases, neurosurgeons typically remove the brain area that triggers the seizures. To pinpoint the precise region responsible, doctors first use an EEG to record brain activity during a seizure by attaching electrodes to the patient’s scalp. If this method does not provide sufficient information, a more invasive approach, the stereo-EEG, is employed, which involves inserting electrodes into the suspected brain areas through small holes drilled into the skull. Although more invasive, stereo-EEG offers higher-resolution recordings of brain activity during seizures compared to traditional EEG. However, this technique only captures the area of the brain with the highest activity and does not track the entire path of the seizure as it spreads. Consequently, the region with the largest signals may indicate the propagation of the seizure and not necessarily the source. As a result, even with this invasive method, surgical success occurs only about 60% of the time.
Now, a new tool developed by neural engineers at Duke Pratt School of Engineering (Durham, NC, USA;) promises to enhance these surgical outcomes by helping neurosurgeons more accurately identify the seizure origins in the brain. The tool, an algorithm called TEDIE (Temporally Dependent Iterative Expansion), collects signals from every implanted electrode and reconstructs the path and changes of neural activity during a seizure. With just brain imaging data and stereo-EEG recordings, TEDIE creates a dynamic "movie" showing where the seizure begins and how it spreads throughout the brain. The algorithm not only identifies the seizure’s point of origin but also provides an estimate of its size. In preliminary tests, TEDIE was applied to simulated seizures with known locations and sizes, outperforming other current algorithms. The team then used TEDIE to analyze stereo-EEG recordings from 46 epilepsy patients.
Their findings, published in the journal Brain, demonstrated that TEDIE’s reconstructions accurately identified the areas that were removed in patients who showed no further epilepsy symptoms after surgery. In contrast, TEDIE also identified seizure origins in patients who continued to experience symptoms after surgery, showing that the removed regions were not the source. Additionally, TEDIE revealed potential new surgical targets in 12 out of 23 patients who still had epilepsy symptoms post-surgery. Encouraged by these results, the team plans to introduce TEDIE into clinical trials. They also aim to adapt the algorithm for use with conventional EEG, potentially reducing the need for invasive stereo-EEG and providing a more accessible tool for epilepsy centers without specialized equipment. Furthermore, TEDIE’s capabilities extend beyond clinical applications, offering valuable insights into brain activity for basic neuroscience research.
“Epilepsy is a very complex disorder. In some individuals, physicians will remove parts of the brain and the patient will get better, but then a year later seizures will return,” said Brandon Thio, a recent PhD graduate and first author of the paper. “TEDIE likely won’t bring the efficacy up to 100%, but we hope that it improves on the current 60% clinical success rate.”
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more